Found 94 clinical trials
Alopecia Areata (patchy hair loss)
Alopecia Areata is an autoimmune disorder that causes patches of hair loss to occur and can lead to significant emotional distress. A research study is now underway in the Miami area to
- 407 views
- 23 Nov, 2020
- 1 location
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata
- 2421 views
- 23 Nov, 2020
- 1 location
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups
- 370 views
- 31 Oct, 2021
- 1 location
AGA Biocellular Stem/Stromal Hair Regenerative Study
) and high density platelet-rich plasma concentrate (HD- PRP) as compared with adipose-derived cell-enriched SVF (AD-cSVF) + AD-tSVF and HD- PRP concentrates in treatment of androgenetic alopecia (AGA
- 84 views
- 28 Jan, 2021
- 1 location
A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
Central centrifugal cicatricial alopecia (CCCA) is form of scarring hair loss that predominately affects middle-aged women of African descent.1 . Clinically, the natural progression of CCCA
- 9 views
- 14 Jan, 2022
- 1 location
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to
- 2003 views
- 22 Dec, 2021
- 63 locations
To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases
Scalp Conditions are common chronic skin inflamations with the occurence rate of 1 - 5 % among the population. TD03 shampoo and TD07 shampoo are widely used to avoid hair loss with successful
- 54 views
- 21 Sep, 2021
- 1 location
A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA2)
This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair
- 35 views
- 03 Dec, 2021
- 65 locations
Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
This is a phase III, single-center, prospective, open-label, randomized,controlled study
- 134 views
- 05 Dec, 2021
- 1 location